PuSH - Publication Server of Helmholtz Zentrum München

19 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Ashton, M.P.* et al.: Association of dendritic cell signatures with autoimmune inflammation revealed by single-cell profiling. Arthritis Rheum. 71, 817-828 (2019)
Hippich, M. et al.: Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families. Diabetes 68, 847-857 (2019)
Laimighofer, M. et al.: Common patterns of gene regulation associated with Cesarean section and the development of islet autoimmunity - indications of immune cell activation. Sci. Rep. 9:6250 (2019)
Peplow, C. et al.: Blood draws up to 3% of blood volume in clinical trials are safe in children. Acta Paediatr. 108, 940-944 (2019)
Winkler, C. et al.: Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results. Pediatr. Diabetes, accepted (2019)
Ziegler, A.-G. et al.: Screening for asymptomatic β-cell autoimmunity in young children. Lancet Child Adolesc. Health 3, 288-290 (2019)
Ziegler, A.-G. et al.: Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol. BMJ Open 9:e028578 (2019)
Beyerlein, A. et al.: Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: Results from the prospective TEDDY study. J. Med. Genet., accepted (2018)
Bonifacio, E.* et al.: Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children. PLoS Med. 15:e1002548 (2018)
Endesfelder, D. et al.: Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119-130 (2018)
Hippich, M. et al.: Searching peripheral blood mononuclear cells of children with viral respiratory tract infections preceding islet autoimmunity for viruses by high-throughput sequencing. Acta Diabetol. 55, 881-884 (2018)
Lynch, K.F.* et al.: Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident beta-cell autoantibodies. J. Autoimmun. 86, 93-103 (2018)
Mehdi, A.M.* et al.: A peripheral blood transcriptomic signature predicts autoantibody development in infants at risk of type 1 diabetes. JCI insight 3:e98212 (2018)
Bonifacio, E.* et al.: Rebranding asymptomatic type 1 diabetes: The case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia 60, 35-38 (2017)
Hommel, A.* et al.: Screening for type 1 diabetes risk in newborns: The Freder1k pilot study in Saxony. Horm. Metab. Res. 50, 44-49 (2017)
Knoop, J. et al.: GM-CSF producing autoreactive CD4(+) T cells in type 1 diabetes. Clin. Immunol. 188, 23-30 (2017)
Köhler, M. et al.: Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: Results from the TEDDY study. Acta Diabetol. 54, 1009–1017 (2017)
Ludwig, B. et al.: Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. Proc. Natl. Acad. Sci. U.S.A. 114, 11745-11750 (2017)
Ziegler, A.-G. et al.: Type 1 diabetes prevention: A goal dependent on accepting a diagnosis of an asymptomatic disease. Diabetes 65, 3233-3239 (2016)